go back

Illinois rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,905,461 · 10th–90th $676,083–$5,370,3180%10%10th90th$1,905,461Professionalmedian $446,684 · 10th–90th $446,684–$446,6840%50%100%$446,684$500.0K$1.0M$2.0M$5.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$676,082.98 / $1,905,460.72 / $5,370,317.96
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$446,683.59 / $446,683.59 / $446,683.59